Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & Administrative
Others
Ratios

Odyssey Health (ODYY) Shares Outstanding (Weighted Average) (2016 - 2021)

Odyssey Health (ODYY) has 8 years of Shares Outstanding (Weighted Average) data on record, last reported at $93.1 million in Q2 2021.

  • For Q2 2021, Shares Outstanding (Weighted Average) rose 6.84% year-over-year to $93.1 million; the TTM value through Apr 2021 reached $93.1 million, up 6.84%, while the annual FY2020 figure was $87.1 million, 24.64% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $93.1 million in Q2 2021 per ODYY's latest filing, down from $94.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $119.8 million in Q2 2018 and bottomed at $14.8 million in Q4 2017.
  • Average Shares Outstanding (Weighted Average) over 5 years is $89.1 million, with a median of $88.7 million recorded in 2020.
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 87.07% in 2017, then surged 313.85% in 2018.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $14.8 million in 2017, then soared by 313.85% to $61.4 million in 2018, then skyrocketed by 41.65% to $87.0 million in 2019, then increased by 3.78% to $90.3 million in 2020, then grew by 3.16% to $93.1 million in 2021.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $93.1 million in Q2 2021, $94.2 million in Q1 2021, and $90.3 million in Q4 2020.